XHKG
0708
Market cap234mUSD
Mar 31, Last price
0.17HKD
Name
China Evergrande New Energy Vehicle Group Ltd
Chart & performance
P/E
—
P/S
120.66
EPS
—
Div yield, %
—
Shrs. gr., 5y
4.65%
Rev. gr., 5y
-71.04%
Revenues
13m
-99.03%
Net income
-891m
L-92.53%
CFO
0
P
Dividend
Dec 04, 20140.0013 HKD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
China Evergrande New Energy Vehicle Group Limited, an investment holding entity, conducts its diverse business operations across the People's Republic of China, Europe, and on an international scale. The enterprise is strategically structured into two main divisions: Health Management and New Energy Vehicle. Under its Health Management segment, the company is involved in the creation and sale of health-focused living properties. It also delivers a range of services, including comprehensive community health programs, advanced medical cosmetology, anti-aging therapies, and extensive elderly care and rehabilitation. Additionally, this division handles the wholesale distribution of home care and various healthcare products, offers healthcare services, and provides software solutions. Its scope further extends to pharmaceutical research and development, along with the production of medical equipment. The New Energy Vehicle division focuses on the research, development, manufacturing, and marketing of new energy vehicles, alongside related vehicle living initiatives. This segment also covers the production and sale of smart mobility products and lithium-ion batteries. Originally founded in 1999 as Evergrande Health Industry Group Limited, the company re-branded to China Evergrande New Energy Vehicle Group Limited in August 2020. Headquartered in Guangzhou, China, it operates as a subsidiary of the China Evergrande Group.
Key people
Executive Chairman of the Board · since 2021
Wai Hong Choi
Executive Director · since 2024
Company Secretary · since 2015
Gar - Gene Leung
Non-Executive Independent Director · since 2024
Wu Xie
Non-Executive Independent Director · since 2015
Legal address
23RD FLOOR, CHINA EVERGRANDE CENTRE 38 GLOUCESTER ROAD, WANCHAI
Hongkong
HK
Hongkong
HK
Headquarters
One Pacific Place, 88 Queensway
Hongkong
HK
Hongkong
HK
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||